# Otsuka Holdings Co., Ltd. (OTSKY)

> Source: Nexqual · https://nexqual.com/OTSKY · data as of 2026-10-23 15:57 UTC · cite as "Nexqual, Otsuka Holdings Co., Ltd. (OTSKY), nexqual.com/OTSKY" · informational, not investment advice.

**Price:** USD 39.61 (+0.38% today) · US market open, as of October 23, 2026 at 15:57 UTC; quotes may be delayed. Prev close 39.46 · day 39.55–39.61 · 52w 26.11–40.92 · market cap $41.6B · PNK

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (1 analysts), mean target USD 49 (range 49–49).
- Total return with dividends: 1Y +44.9% vs S&P 500 +14.4%; 5Y +104.8% vs S&P 500 +77.0%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 49 (low 49, high 49).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +44.9% | +104.8% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +45.0% | +15.4% |
| Volatility (annualized) | 33.9% | 28.0% |
| Max drawdown | -14.0% (Apr 2026→Jun 2026) | -28.6% (Nov 2024→Jul 2025) |

## Peers (Drug Manufacturers - General)
BIIB (Biogen Inc.) USD 250.54 -1.30% · SNY (Sanofi) USD 41.51 -1.07% · GSK (GSK plc) USD 50.66 -1.08% · BMY (Bristol-Myers Squibb Company) USD 61.57 -2.27% · PFE (Pfizer, Inc.) USD 29.98 -1.46% · NVO (Novo Nordisk A/S) USD 39.03 -1.03%

## More
Full page: https://nexqual.com/OTSKY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $703.79B | — |
| Next quarter (ends 2026-12-31) | — | — | — | $713.00B | — |
| Current fiscal year (ends 2026-12-31) | $2.16 | $1.86 | +16.2% | $2.75T | 1 |
| Next fiscal year (ends 2027-12-31) | $2.25 | $1.97 | +13.9% | $2.82T | 1 |